# A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants

> **NCT06189508** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 48 (actual)

## Conditions studied

- Healthy Male Participants

## Interventions

- **DRUG:** NXT007

## Key facts

- **NCT ID:** NCT06189508
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-14
- **Primary completion:** 2024-12-22
- **Final completion:** 2024-12-22
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06189508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06189508, "A Study to Evaluate Single Subcutaneous Doses of NXT007 Among Injection Sites Abdomen, Upper Arm, and Thigh in Healthy Male Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06189508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*